Global Monoclonal Antibodies Market Analysis and Forecast 2019-2028

Market Introduction: Key Takeaways

The global monoclonal antibodies market is expected to grow at a CAGR of 9.2% during the forecast period of 2023-2028, according to a recent market report. Monoclonal antibodies (mAbs) are laboratory-made molecules that can mimic the immune system’s ability to fight off harmful pathogens such as cancer cells, viruses, and other diseases.

Market Drivers and Trend Analysis

The growth of the global monoclonal antibodies market is driven by several factors, including the increasing prevalence of chronic diseases such as cancer, autoimmune diseases, and infectious diseases, as well as the growing adoption of mAbs for targeted therapy due to their high specificity and low toxicity. The rising demand for personalized medicine and advancements in biotechnology and genomics are also contributing to the growth of the market.

The report identifies several challenges facing the global monoclonal antibodies market, including the high cost of mAbs and the complex regulatory landscape for their development and approval. The availability of alternative therapies and the potential risk of adverse events associated with mAbs are also identified as challenges.

Key Segmental Analysis

Based on application, the report identifies cancer as the largest segment of the global monoclonal antibodies market, accounting for the majority of the market share. This is due to the increasing prevalence of cancer worldwide and the growing adoption of mAbs as targeted therapy for various types of cancer. Other applications of mAbs, such as autoimmune diseases, infectious diseases, and cardiovascular diseases, are also expected to contribute to market growth.

Global and Regional Market Analysis – Based on Market Intelligence 

Regionally, North America is the largest market for monoclonal antibodies, driven by the high prevalence of chronic diseases, well-established healthcare infrastructure, and favorable reimbursement policies. Europe is also a significant market for mAbs, with increasing adoption of these therapies in countries such as Germany, France, and the UK. The Asia-Pacific region is expected to witness the fastest growth, driven by the increasing healthcare expenditure, rising prevalence of chronic diseases, and growing awareness and adoption of targeted therapies.

Competition Overview: Market Structure and Leading Players

The global monoclonal antibodies market is highly competitive and includes several major market players. Some of the key market players operating in the global monoclonal antibodies market, as identified in the market report, include F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Pfizer Inc., Novartis International AG, Merck & Co., Inc., AbbVie Inc., Bristol-Myers Squibb Company, Amgen Inc., Eli Lilly and Company, AstraZeneca plc, Regeneron Pharmaceuticals, Inc., Sanofi S.A., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, and Takeda Pharmaceutical Company Limited among others.

Key Market Segmentation: Global Monoclonal Antibodies Market

Rationalstat has segmented the global monoclonal antibodies market on the basis of type, application, region and end user.

• By Region
  • North America
    • US
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Chile
    • Peru
    • Argentina
    • Rest of Latin America
  • Western Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Benelux
    • Nordic Countries
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Poland
    • Hungary
    • Czech Republic
    • Rest of Eastern Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • ASEAN (Indonesia, Vietnam, Thailand, Philippines, Malaysia, etc.)
    • Rest of Asia Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Turkey
    • Egypt
    • Sub-Saharan
    • Rest of the Middle East & Africa

Research Methodology

RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts’ viewpoint to create a research methodology for market sizing and forecasting.

RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:

• Defining the problem by understanding the type of market and data required by the client.
• Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews.
• Formulating a hypothesis to create market numbers, forecasts, influencing factors, and their relevance.
• Evaluating and analyzing the data by referring to data sources utilized and leveraged.
• Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts.

Primary Intelligence

• RationalStat utilizes surveys, questionnaires, focus groups, and one-to-one interviews with CXOs, industry partners, trade bodies, association members, ex-employees, and industry professionals to collect insights and quantitative/qualitative data specific to client needs. RationalStat quickly gets to the ‘why’ behind the ‘what’ demonstrated by secondary data.
• RationalStat takes a unique approach to arrive at market conclusions and actionable insights for clients.
• We have the technology and strong in-house resource pool with extensive experience in the global and regional markets, across a wide variety of categories and stakeholders.
• Strong language proficiency and capability with coverage across more than 70 language areas.

Secondary Sources

• Annual reports, company filings, investor presentations, product catalogs, and company documents
• Industry and market-related documents available in the public domain
• Paid databases including Bloomberg, Factiva, S&P Capital IQ, FactSet, Refinitiv Eikon, ICIS, EUWID, and Thomson Reuters, among others
• Whitepapers, research papers, and industry blogs

Why Buy this Report?

The report is intended for service providers, manufacturers, industry stakeholders, government organizations, marketing departments, R&D professionals, insurance organizations, regulatory agencies, and market research firms, among others. The report provides an in-depth analysis of market size, consumption patterns, ongoing market trends and challenges, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights to clients to find the right answers to their business questions.